Online citations, reference lists, and bibliographies.
← Back to Search

Temporal Patterns In The Medical Treatment Of Congestive Heart Failure With Angiotensin-converting Enzyme Inhibitors In Older Adults, 1989 Through 1995.

N. Smith, B. Psaty, B. Pitt, R. Garg, J. Gottdiener, S. Heckbert
Published 1998 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
BACKGROUND Evidence from clinical trials in the past decade has consistently shown that angiotensin-converting enzyme (ACE) inhibitors reduce morbidity and mortality in patients with congestive heart failure (CHF). The extent to which clinical practice has adopted ACE inhibitor therapy is unknown. METHODS The Cardiovascular Health Study is a prospective observational study of 5201 community-dwelling adults aged 65 years and older. Prevalent CHF cases were identified on study entry (from June 10, 1989, through May 31, 1990) and incident CHF cases were identified throughout 5 years of follow-up. Medication data were collected from annual medication inventories. The percentage of patients with CHF using ACE inhibitors was calculated at each annual examination. Temporal trends in CHF treatment with ACE inhibitors between June 10, 1989, through May 31, 1990, and June 1, 1994, through May 31, 1995, were analyzed. RESULTS Use of ACE inhibitors to treat CHF increased slightly over time among prevalent cases at each annual examination: 26% of prevalent CHF cases were treated in 1989-1990 compared with 36% of prevalent cases in 1994-1995. This 10% increase was statistically significant (P<.01). Participants with low ejection fractions were 2 times more likely to be treated with ACE inhibitors than were those with normal ejection fraction and this tendency did not change over time. Among cases newly diagnosed in the year before the 1990-1991 examination, 42% were using ACE inhibitors; among those newly diagnosed in the year before 1994-1995, 40% were using ACE inhibitors. This 2% decrease was not statistically significant (P=.68). CONCLUSION These findings suggest that, while the medical management of CHF with ACE inhibitors has increased modestly over time in prevalent cases, these drugs may still be underused, especially among incident cases.
This paper references
10.2307/2982107
Statistical methods for rates and proportions
J. Fleiss (1974)
10.1056/NEJM198610023151402
Comparison of captopril and enalapril in patients with severe chronic heart failure.
M. Packer (1986)
10.1214/SS/1177013815
Bootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical Accuracy
B. Efron (1986)
10.1016/S0002-9149(88)80087-0
Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).
K. Swedberg (1988)
10.1016/S0002-9149(88)80088-2
Tolerability of enalapril in congestive heart failure.
J. Kjekshus (1988)
10.1177/000331979104200506
ACE Inhibitors in the Elderly
E. Posvar (1991)
10.1016/1047-2797(91)90005-W
The Cardiovascular Health Study: design and rationale.
L. Fried (1991)
10.1159/000174903
Duration of angiotensin-converting enzyme inhibition: implications for tolerability.
N. H. Murray (1991)
10.1056/NEJM199108013250501
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.
S. Yusuf (1991)
10.1056/NEJM199209033271003
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.
S. Yusuf (1992)
10.1056/NEJM199209033271001
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.
M. Pfeffer (1992)
10.2165/00002018-199207010-00004
Adverse Effects of Angiotensin Converting Enzyme (ACE) Inhibitors
R. Parish (1992)
10.1016/0895-4356(92)90143-B
Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study. The Cardiovascular Health Study Collaborative Research Group.
B. Psaty (1992)
10.1016/0735-1097(94)90585-1
Trends in the use of drug therapies in patients with acute myocardial infarction: 1988 to 1992.
C. Pashos (1994)
10.1016/0735-1097(94)00552-2
Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice.
S. Viskin (1995)
10.1001/JAMA.1995.03520420052037
Temporal patterns of antihypertensive medication use among older adults, 1989 through 1992. An effect of the major clinical trials on clinical practice?
B. Psaty (1995)
10.1056/NEJM199504273321703
Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings?
S. Andrade (1995)
10.1161/01.CIR.92.10.2841
Aspirin in the treatment of acute myocardial infarction in elderly Medicare beneficiaries. Patterns of use and outcomes.
H. Krumholz (1995)
10.1056/NEJM199510193331614
Alcohol consumption and mortality among women.
Lowenfels Ab (1995)
10.1097/00007611-199505000-00002
Patterns of Medication Use in Patients With Heart Failure: A Report From the Registry of Studies of Left Ventricular Dysfunction (SOLVD)
J. Young (1995)
10.1016/1047-2797(94)00092-8
Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study.
B. Psaty (1995)
10.1001/JAMA.1995.03520420066040
Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure
R. Garg (1995)
10.1016/1047-2797(94)00093-9
Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study.
D. Ives (1995)
10.1016/S0002-9149(97)89177-1
Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals.
E. Philbin (1996)
10.1001/ARCHINTE.156.7.799
Adherence to National Guidelines for Drug Treatment of Suspected Acute Myocardial Infarction: Evidence for Undertreatment in Women and the Elderly
T. Mclaughlin (1996)
Pharmacologic management of heart failure among older adults by office-based physicians in the United States.
J. Croft (1997)
10.1046/j.1365-2796.1997.129150000.x
Congestive heart failure in old age: prevalence, mechanisms and 4‐year prognosis in the Helsinki Ageing Study
M. Kupari (1997)
10.1093/OXFORDJOURNALS.EURHEARTJ.A015387
The prevalence of left ventricular diastolic filling abnormalities in patients with suspected heart failure.
A. Davie (1997)



This paper is referenced by
Prescription pattern in patients having heart failure in a south Indian tertiary care hospital: A retrospective study
A. Rao (2017)
10.1001/jama.2017.10565
Effect of Natriuretic Peptide–Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial
G. M. Felker (2017)
Comparison of Captopril with Enalapril on Improvement of Systolic and Diastolic Heart Functions in Asymptomatic Patients Over 10 Years Old with Beta- Thalassemia Major
Noor Mohammad Noori (2015)
Health-related Quality of Life and Mortality in Incident Heart Failure from the Cardiovascular Health Study (CHS)
Patricia C. Woltz (2014)
10.1016/j.sapharm.2009.06.004
Prescribing trends for management of congestive heart failure from 2002 to 2004.
Tonya Crawford (2013)
10.1007/s11897-012-0117-5
Trends In Heart Failure Hospitalizations
N. Fida (2012)
10.2165/00019053-199915060-00002
Angiotensin Converting Enzyme (ACE) Inhibitors and Heart Failure
F. Andersson (2012)
10.2165/00003495-200161140-00002
Underutilisation of ACE Inhibitors in Patients with Congestive Heart Failure
T. Bungard (2012)
10.1111/j.1945-1474.2010.00124.x
Heart Failure Patients Receiving ACEIs/ARBs were Less Likely to be Hospitalized or to Use Emergency Care in the Following Year
J. Chen (2011)
Ambulatory Heart Failure Treatment: Process and Outcomes Effects of Provider Practice and Patient Adherence
Eric D. Hixson (2009)
10.1007/978-1-60327-362-6_22
Drug–Nutrient Interactions in the Elderly
B. Kinosian (2009)
10.1111/j.1532-5415.2009.02407.x
Clinical Features, Treatment Practices, and Hospital and Long‐Term Outcomes of Older Patients Hospitalized with Decompensated Heart Failure: The Worcester Heart Failure Study
J. Saczynski (2009)
10.1016/S1262-3636(07)80055-3
Congestive heart failure in the elderly diabetic.
C. Verny (2007)
10.2165/00002512-200724110-00006
Do ACE Inhibitors/Angiotensin II Type 1 Receptor Antagonists Reduce Hospitalisations in Older Patients with Heart Failure?
Coralynn B Trewet (2007)
10.1016/J.AHJ.2007.03.012
Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE).
G. Fonarow (2007)
10.1016/j.ejheart.2007.09.008
Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey
P. Groote (2007)
Chronic Heart Failure in the Elderly – Clinical Implications
prace poglądowe (2006)
10.1016/J.AHJ.2005.04.022
Mortality benefit of a comprehensive heart failure disease management program in indigent patients.
K. Hebert (2006)
10.1016/J.CLINTHERA.2005.06.014
Use of valsartan for the treatment of heart-failure patients not receiving ACE inhibitors: a budget impact analysis.
Dean G Smith (2005)
10.2143/AC.60.4.2004988
Informative value of clinical markers for the risk of cardiovascular death in postinfarction chronic heart failure
R. Zaliunas (2005)
10.1159/000083665
ACE Inhibitors for Older Patients with Heart Failure: A Review of Evidence, Practice Patterns and Challenges
Pamela N. Peterson (2005)
10.1016/J.IJCARD.2004.10.028
Temporal improvement in heart failure survival related to the use of a nurse-directed clinic and recommended pharmacological treatment.
B. Andersson (2005)
10.1016/j.ejheart.2005.07.002
Practical recommendations for the use of ACE inhibitors, beta‐blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice
J. McMurray (2005)
10.1136/pgmj.2004.026716
Device based treatment of heart failure
A. Patwala (2005)
10.1111/J.1076-7460.2004.02124.X
Medications and cardiovascular health in older adults: room for improvement in prevention and treatment.
C. Rhoads (2004)
10.1016/J.IJCARD.2003.04.027
A survey of outpatient management of elderly heart failure patients in Poland-treatment patterns.
T. Rywik (2004)
10.1111/j.1365-2710.2004.00549.x
Spironolactone use in patients with heart failure
J. Trujillo (2004)
10.1023/A:1021794229020
High Dose Lisinopril in Heart Failure: Economic Considerations
S. M. Ess (2004)
, in Older Patients With Heart Failure and Left Ventricular Systolic Dysfunction National Patterns of Use and Effectiveness of Angiotensin-Converting Enzyme Inhibitors
F. Masoudi (2004)
10.1161/01.CIR.0000138934.28340.ED
National Patterns of Use and Effectiveness of Angiotensin-Converting Enzyme Inhibitors in Older Patients With Heart Failure and Left Ventricular Systolic Dysfunction
F. Masoudi (2004)
10.1016/j.ejheart.2004.09.003
Aetiology, comorbidity and drug therapy of chronic heart failure in the real world: the EPICA substudy
F. Ceia (2004)
10.1097/00006205-200407000-00008
CHF in the elderly using ACEIs appropriately.
Lisa M Naylor (2004)
See more
Semantic Scholar Logo Some data provided by SemanticScholar